212 related articles for article (PubMed ID: 24901056)
1. CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.
Shang B; Gao A; Pan Y; Zhang G; Tu J; Zhou Y; Yang P; Cao Z; Wei Q; Ding Y; Zhang J; Zhao Y; Zhou Q
Cell Death Dis; 2014 Jun; 5(6):e1285. PubMed ID: 24901056
[TBL] [Abstract][Full Text] [Related]
2. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
Tang F; Tang S; Guo X; Yang C; Jia K
Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
[TBL] [Abstract][Full Text] [Related]
3. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q
Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456
[TBL] [Abstract][Full Text] [Related]
4. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
Yang P; Huo Z; Liao H; Zhou Q
Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
[TBL] [Abstract][Full Text] [Related]
5. CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.
Wen M; Ren H; Zhang S; Li T; Zhang J; Ren P
Cell Death Dis; 2021 Jun; 12(7):650. PubMed ID: 34172717
[TBL] [Abstract][Full Text] [Related]
6. The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic
Yang P; Qiao Y; Liao H; Huang Y; Meng M; Chen Y; Zhou Q
J Breast Cancer; 2023 Apr; 26(2):168-185. PubMed ID: 37095619
[TBL] [Abstract][Full Text] [Related]
7. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
8. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
[TBL] [Abstract][Full Text] [Related]
9. Uev1A promotes breast cancer cell migration by up-regulating CT45A expression via the AKT pathway.
Niu T; Wu Z; Xiao W
BMC Cancer; 2021 Sep; 21(1):1012. PubMed ID: 34503444
[TBL] [Abstract][Full Text] [Related]
10. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
11. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
Son J; Lee JH; Kim HN; Ha H; Lee ZH
Biochem Biophys Res Commun; 2010 Jul; 398(2):309-14. PubMed ID: 20599715
[TBL] [Abstract][Full Text] [Related]
12. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
13. TGF-β upregulates miR-181a expression to promote breast cancer metastasis.
Taylor MA; Sossey-Alaoui K; Thompson CL; Danielpour D; Schiemann WP
J Clin Invest; 2013 Jan; 123(1):150-63. PubMed ID: 23241956
[TBL] [Abstract][Full Text] [Related]
14. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
[TBL] [Abstract][Full Text] [Related]
15. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
16. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1.
Feng YX; Jin DX; Sokol ES; Reinhardt F; Miller DH; Gupta PB
Nat Commun; 2017 Oct; 8(1):1079. PubMed ID: 29057869
[TBL] [Abstract][Full Text] [Related]
17. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE
Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731
[TBL] [Abstract][Full Text] [Related]
18. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
20. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
Leontovich AA; Zhang S; Quatraro C; Iankov I; Veroux PF; Gambino MW; Degnim A; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Int J Oncol; 2012 Jun; 40(6):1858-64. PubMed ID: 22447278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
